Human Nectin-4-coupled Magnetic Beads
背景（Background）
The Human Nectin-4-coupled Magnetic Beads is produced by coupling biotinylated human Nectin-4 protein to streptavidin-conjugated magnetic beads. The pre-coupled beads are ready to use for capturing anti-Nectin-4 antibody from your sample with high specificity.
表達(dá)區(qū)間及表達(dá)系統(tǒng)（Source）
Human Nectin-4 Protein is expressed from human 293 cells (HEK293). It contains AA Gly 32 - Ser 349(Accession # Q96NY8-1).
應(yīng)用說明（Application）
This product is intended for immunocapture, biopanning and flow cytometry. This product is produced non-sterile.
The Isotype control (Cat. No. SMB-B01) is sold separately.
重構(gòu)方法（Reconstitution）
See Certificate of Analysis (CoA) for detailed instruction.
存儲（Storage）
Upon receipt, please store the Beads at -20°C. The shelf life is 6 months at -20 °C.
Please avoid more than 3 freeze-thaw cycles once reconstitution, immediate use after reconstitution is highly recommended.
原理（Assay Principles）
Antibody Purification:
1. Reconstitute the beads with ultrapure water to 1 mg/mL, and wash the beads for three times.
2. Dilute the biotinalyted protein or antibodies with Assay Buffer and add to the beads. Incubate for 60 minutes at room temperature in a rotary mixer.
3. Wash the beads for four times, and add Assay Buffer to the beads. The beads are ready to use for the next experiment.
The magnetic beads technology makes use of the easy and efficient collection of beads in magnetic field to facilitate antibody purification in a simple workflow of “bind-wash-elute”. In contrast to common separation techniques, this method does not require columns or centrifugation, and is therefore ideal in high-throughput applications.
制劑（Formulation）
Please contact us for detailed information.
Contact us for customized product form or formulation.
關(guān)鍵字： Nectin-4磁珠;Nectin-4 Beads;Magnetic Beads;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group（股票代碼：301080）是成立于2010年的跨國生物科技公司，是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球，橫跨亞洲、北美洲、歐洲，在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家，與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。